X

LATEST

After a weak first half, will NIKE (NKE) hit the recovery path this year?

After a prolonged slowdown, NIKE, Inc. (NYSE: NKE) is working on a turnaround plan to regain the brand’s strength. In…

FedEx Q2 2025 Earnings Call: Listen Live and Follow Along with the Real-Time Transcript

FedEx Corporation (NYSE: FDX) is scheduled to report second-quarter 2025 earnings today at 4:00 p.m. ET. It is estimated that…

“Gelteq has been continuously evolving to expand applications and audiences”

Gelteq Limited (NASDAQ: GELS) is a healthcare company specializing in the development and manufacturing of edible gel products, with a…

Micron Q1 2025 Earnings Call: Listen Live and Follow Along with the Real-Time Transcript

Semiconductor company Micron Technology Inc. (NASDAQ: MU) is expected to report first-quarter 2025 results today after regular trading hours. Listen…

Broadcom Q4 2024 Earnings: Stay tuned for the live earnings call and real-time transcript

Semiconductor company Broadcom, Inc. (NASDAQ: AVGO) is expected to report fourth-quarter 2024 results today at 4:15 p.m. ET. The market…

Oracle Q2 2025 Earnings Call: Listen Live and Follow Along with the Real-Time Transcript

Software giant Oracle Corporation (NYSE: ORCL) is preparing to report its second-quarter 2025 financial results today after the closing bell.…

Hewlett Packard Q4 2024 Earnings Call: Listen Live and Follow Along with the Real-Time Transcript

Information technology solutions provider Hewlett Packard Enterprise (NYSE: HPE) is expected to report fourth-quarter 2024 results today after the closing bell.…

Salesforce Q3 2025 Earnings: Stay tuned for the live earnings call and real-time transcript

Customer relationship management platform Salesforce, Inc. (NYSE: CRM) will be reporting third-quarter 2025 financial results today after the closing bell.…

HP Q4 2024 Earnings: Stay tuned for the live earnings call and real-time transcript

Technology leader HP Inc. (NYSE: HPQ) is scheduled to publish earnings results for the fourth quarter of 2024 today after…

Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO

Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer…